이상반응 보고
| VAERS ID | 1863349 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | |
| 제약회사 | JANSSEN |
| 로트 번호 | |
| 예방접종 횟수 | |
| 접종일 | |
| 발병일 | 2021-10-12 |
| 상태 | 입원 회복 |
증상
- 현기증(Dizziness)
- 호흡곤란(Dyspnoea)
- 실신(Malaise)
- 근육통(Myalgia)
- 실명 일시적(Blindness transient)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
Multigravida (Four previous pregnancies / Three live babies)
지병
Medical History/Concurrent Conditions: Miscarriage (One previous pregnancy)
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
COULD NOT SEE; MATERNAL EXPOSURE DURING PREGNANCY; COULD NOT BREATHE; DIZZINESS; FEELING UNWELL; MUSCLE PAIN; This solicited pregnancy report received from a consumer concerned a 38 year old female of unknown race and ethnicity.
The patient was enrolled in a non-company sponsored study.
The patient's height, and weight were not reported.
The patient's past medical history included: miscarriage (one), and concurrent conditions included: multigravida (four previous pregnancies, three resulting in a live baby).
The patient initiated treatment with covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin not reported, batch number: 211A21A expiry: UNKNOWN) dose was not reported, 1 total was administered on 12-OCT-2021 for covid-19 immunisation.
No concomitant medications were reported.
The first day of the last menstrual period (LMP) was calculated to be 06-Mar-2021.
The estimated delivery date (EDD) was reported to be 11-Dec-2021.
Type of pregnancy was not reported.
On 12-Oct-2021 (at the time of vaccination), patient was at gestational age of 31 weeks and three days.
On 12-OCT-2021, the patient experienced maternal exposure during pregnancy, muscle pain, dizziness, was feeling unwell and could not see or breathe.
All reported events led to emergency room and subsequently hospital admission.
The patient received intravenous infusion and medical attention.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The patient recovered from could not see, could not breathe, dizziness, feeling unwell, and muscle pain on 13-OCT-2021, and the outcome of maternal exposure during pregnancy was not reported.
The reporter provided no causality assessment.
Company causality between covid-19 vaccine ad26.
cov2.
s, and maternal exposure during pregnancy was not related, and between covid-19 vaccine ad26.
cov2.
s, and could not see, could not breathe, dizziness, feeling unwell, and muscle pain was related.
This report was serious (Hospitalization Caused / Prolonged).
; Sender's Comments: V0: 20211118554-COVID-19 VACCINE AD26.
COV2.
S- Could not see, Could not breathe, Dizziness.
This event(s) is considered related.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
20211118554-COVID-19 VACCINE AD26.
COV2.
S-Maternal exposure during pregnancy.
This event is considered not related.
The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There are other factors more likely to be associated with the event than the drug.
Specifically: SPECIAL SITUATIONS 20211118554-COVID-19 VACCINE AD26.
COV2.
S- Feeling unwell, Muscle pain.
This event(s) is labeled per RSI and is therefore considered potentially related.